Skip to main
LITS
LITS logo

MEI Pharma Inc (LITS)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy LITS Stock

About MEI Pharma Inc (LITS)

Lite Strategy, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.
Market cap$74.16M
Yesterday's volume1.16M
Revenue (TTM)
Avg. daily volume998.09K
EBITDA (TTM)-$17.09M
Open$2.12
Price / earnings ratio-0.87x
Yesterday's range$1.99 - $2.18
Debt / equity
52 week range$1.46 - $9
5 year debt / equity15.5x
Beta (LTM)0.63x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio13.5x
Ex-dividend date
Next earningsNov 11, 2025
Dividend payable date

Frequently Asked Questions (FAQ)

As of Oct 29, 2025, the market cap for LITS stock is $74.17M

The current P/E ratio for LITS stock is -0.87

The 52-week high for LITS stock is $9. The current LITS stock price $undefined is 100.00% below its 52-week high

The 52-week low for LITS stock is $1.46. The current LITS stock price $undefined has increased 100.00% from its 52-week low

No, the LITS stock does not pay dividends to its shareholders

How to buy LITS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in LITS stock

    Navigate to the Explore page. Then, type LITS into the search bar. When you see LITS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased LITS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

MEI Pharma Inc Stock Earnings

The value each LITS share was expected to gain vs. the value that each LITS share actually gained.

LITS (LITS) reported Q4 2024 earnings per share (EPS) of -$1.12, beating estimates of -$1.43 by 21.68%. In the same quarter last year, LITS's earnings per share (EPS) was -$1.51. LITS is expected to release next earnings on 11/11/2025, with an earnings per share (EPS) estimate of $0.

Buy LITS Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.